Page 52 - GM_2018_6
P. 52

COUNTRY OUTLOOK
         Country outlook
             since 1998, when it acquired Kangar Consolidated
             Industries (KCI) as part of its takeover of Kangar’s
             Australian parent company, ACI Glass Packaging.
             Kangar Consolidated has been engaged in container
             glass production in the country since 1973.
               Owens Illinois’s Indonesian plant is based in the
             Jakarta suburban area of Cakung. It consists of two
             furnaces and six machine lines with an installed capacity
             of 2.64 million bottles per day. The American company
             underwent an expansion programme in 2014 to increase
             the installed capacity from 2.23 million bottles per day
             to the current capacity. During the same expansion, O-I
             also adopted NNPB technology at its Indonesian manu-
             facturing facility.
               O-I Indonesia supplies container glass to major
             brands of food, beverages, and pharmaceutical com-
             panies such as PT Multi Bintang Tbk, Kratingdaeng,
             Sambal Indofood, Hemaviton, and Marjan syrup,Coca
             Cola, Heineken, Heinz, Danone, Nestle, Unilever, PT
             Asia Health Energy Beverage, PT Djojonegoro, PT
             Supra Ferbindo Farma and Ultra Prima Adadi.

             PT Schott Igar Glass
               PT Schott Igar Glass, a subsidiary of German con-
             tainer glass manufacturer Schott, is a leading pharma-
             ceutical glass manufacturer in Indonesia. Schott entered
             Indonesia in 1996 by means of a joint venture with the
             pharmaceutical manufacturer PT Kalbe Farma. In 1997,
             Schott purchased Kalbe’s 51 per cent stake in the ven-
             ture and consolidated the Indonesian company under
             Schott International.
               The Indonesian factory is located on an area of
             30,000 square meters in Bekasi, and has 70 produc-
             tion lines. The state of the art manufacturing facility
             is capable of producing 700 million vials, ampoules,
             pipettes and special articles for the pharmaceutical
             market every year. A number of leading global pharma-
             ceutical producing companies such as Roche, Aventis
             and Pharmacia and local companies like Biofarma and
             Harsen are among the company’s customers. About 60
             per cent of its products are sold locally, while the rest is
             exported to about 20 markets in ASEAN countries, the
             Middle East, India and Pakistan. O
   47   48   49   50   51   52   53   54   55   56   57